30
total announcements
NEPHROPLUS.NS · 15 min delayed
Nephrocare Health Services Limited
Nephrocare Health Services Limited has announced its Q1 FY27 earnings, with revenues growing more than 20% year-on-year, driven by the strength of its platform business and disciplined execution.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about an Asset Transfer Agreement entered into by its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., with Assumption Dialysis Center for the acquisition of identified assets related to a dialysis center in the Philippines for a total consideration of PhP 75,000,000.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 12, 2026, and informed the Exchange regarding voting results.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about the schedule of an investor conference to be held on 18th August, 2026, at Grand Hyatt, Mumbai.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about entering into an Asset Transfer Agreement with Juan Nephro Dialysis Center for the acquisition of identified assets relating to a dialysis center in Davao City, Philippines, for a total consideration of PhP 71,800,000.
Nephrocare Health Services Limited
Nephrocare Health Services Limited clarifies the status of its step-down subsidiary, NPHSK LLP, incorporated in Kazakhstan, stating it is a step-down subsidiary of the Company, not a step-down wholly owned subsidiary.
Nephrocare Health Services Limited
Nephrocare Health Services Limited held its 17th Annual General Meeting on August 12, 2026, through video conferencing, with 74 members in attendance. The meeting was chaired by Mr. Vikram Vuppala, Chairman and Managing Director, and the statutory auditor's report did not contain any qualifications or reservations.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about the link of the audio recording of the Investors' Conference Call held on August 12, 2026, to discuss the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per Regulation 32 of the SEBI LODR Regulations, 2015, and Regulation 41 of the SEBI ICDR Regulations, 2018. The report, issued by Crisil Ratings Limited, Monitoring Agency, provides an objective view of the utilization of the issue proceeds in relation to the objects of the Initial Public Offer (IPO).
Nephrocare Health Services Limited
Nephrocare Health Services Limited, Asia's largest dialysis network under the brand 'NephroPlus', announced its Financial Results for first quarter ended 30th June 2026, with revenue growing 23.7% YoY to ₹281.8 crore and Adjusted EBITDA growing 30.7% YoY to ₹65.1 crore.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about Investor Presentation, which includes unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the reconstitution of the Audit Committee and Stakeholders Relationship Committee. The company also announced the proposed transfer of 51% shareholding in Nephrocare Health Services Saudi Arabia Company to NephroPlus Kidney Services Company as part of an internal restructuring of the Group's overseas holding structure.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about a scheduled investor conference on August 13-14, 2026, where company officials will discuss publicly available information with investors.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about the schedule of its Q1FY27 Earnings Call, to be held on August 12, 2026, at 10:00 A.M IST, where the management will discuss the company's unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about the dispatch of Notice of 17th Annual General Meeting of the Company along with the Annual Report of the Company for the financial year 2025-26 and information on remote e-voting.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about General Updates, including the dispatch of a letter providing a web-link of the Annual Report for FY 2025-26 along with AGM Notice. The company has completed the dispatch of the letter to those Members who have not registered their email address with the Company/RTA/Depositories. The Annual Report 2025-26 is also available on the websites of Stock Exchanges.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about a Copy of Newspaper Publication regarding the Notice of the 17th Annual General Meeting (AGM) and Cut-off date.
Nephrocare Health Services Limited
Nephrocare Health Services Limited has informed the Exchange about Options to purchase securities - Pursuant to Reg 30 of SEBI Listing Regulations, 2015, the Company has approved allotment of 2,18,297 equity shares of face value of Rs. 2/- each, pursuant to the exercise of stock options under the NephroPlus ESOP Scheme 2011.